Program
VDPHL01
A development code. Also written as “VDPHL01 QD” and “VDPHL01 BID”.
Its studies are mostly in Alopecia, led by Veradermics.
Furthest: phase 3, since Dec 4, 20244 company-led studies, 4 open or runningNext primary completion: Dec 2026 (phase 3)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Veradermics | 44 open or running | phase 3since Dec 4, 2024 | Jul 25, 2024 | Dec 2026phase 3 · NCT06972264 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jul 25, 2024First study: phase 2 study in AlopeciaFirst studyNCT06527365 · 70 enrolled · United States
- Dec 4, 2024Phase 3 study in AlopeciaNCT06724614 · 480 enrolled · United States
- May 6, 2025Phase 3 study in AlopeciaNCT06972264 · 480 enrolled · United States
- Aug 12, 2025Phase 3 study in AlopeciaNCT07146022 · 552 enrolled · United States
Ahead
- Dec 2026Primary completion: phase 3 study in AlopeciaNCT06972264
- Jun 2027Primary completion: phase 3 study in AlopeciaNCT07146022
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07146022Alopecia · United States | 3 | Active, not recruiting | Jun 2027 | 552 |
| NCT06972264Alopecia · United States | 3 | Active, not recruiting | Dec 2026 | 480 |
| NCT06724614Alopecia · United States | 3 | Active, not recruiting | Feb 2026 | 480 |
| NCT06527365Alopecia · United States | 2 | Active, not recruiting | Aug 2026 | 70 |
How it is read
Names in the registry
- “VDPHL01”, 3 entries
- “VDPHL01 QD”, 1 entry
- “VDPHL01 BID”, 1 entry
Codes read as this program: VDPHL01.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.